Astellas CEO Says Seeks to Buy 90% Of OSI Shares

17.05.2010 - Astellas Pharma, Japan's No.2 drugmaker, seeks to buy at least 90% of shares in U.S. drugmaker OSI Pharmaceuticals with its tender offer, the company's chief executive said on...